Analytische Chemie
Filtern
Dokumenttyp
Sprache
- Englisch (2)
Schlagworte
- Fluorescent dye (2) (entfernen)
Organisationseinheit der BAM
Molecularly Imprinted Polymer Embedded BODIPY Probes for the Fluorescence Detection of Antibiotics
(2021)
Antibiotics are widely used to combat bacterial infections in humans and animals and their use has greatly improved modern healthcare. However, frequent and reckless use of antibiotics can cause antibiotic resistance in bacteria and pollute ecosystems. Therefore, the rapid and reliable detection of antibiotics is crucial. Fluorescence sensing is particularly attractive because of its high sensitivity and low limits of detection. Fluorescence assays can be carried out in a variety of platforms such as strips and particles among others. Recently, core-shell molecularly imprinted polymers (MIPs) have emerged as a promising sensor platform for (bio)chemical detection due to their low-cost, high stability, reusability, high affinity and selectivity.MIPs in combination with fluorescent molecular probes are gorgeous, since the covalently embedded probe allows for direct indication of a rebound template and provides a wealth of information about the binding state of a MIP through the multitude of fluorescence parameters accessible, facilitating MIP optimization.
In the present work, we have developed a novel series of fluorescent functional monomers, which consist of a fluorophore with a π-conjugated urea recognition site and one or two polymerizable units. The fluorescent monomers are covalently embedded into the MIP matrix to generate fluorescence changes upon template binding (Figure 1). Preliminary titrations of the dye monomer with the analytes show a blue shift of the absorption spectrum and a decrease in the fluorescence intensity which confirms the formation of hydrogen bonds between the urea and the carboxylate group of the antibiotic. Compared with the non-imprinted polymers, the MIP shells on core carrier particles have demonstrated an effective imprinting by showing a higher fluorescence response upon analyte binding.
Using fluorescence-guided surgery (FGS) to cytoreductive surgery helps achieving complete resection of microscopic ovarian tumors. The use of visible and NIR-I fluorophores has led to beneficial results in clinical trials; however, involving NIR-II dyes seems to outperform those benefits due to the deeper tissue imaging and higher signal/noise ratio attained within the NIR-II optical window. In this context, we developed NIR-II emitting dyes targeting human epidermal growth factor receptor 2 (HER2)-positive ovarian tumors by coupling water-soluble NIR-II aza-BODIPY dyes to the FDA-approved anti-HER2 antibody, namely, trastuzumab. These bioconjugated NIR-II-emitting dyes displayed a prolonged stability in serum and a maintained affinity toward HER2 in vitro. We obtained selective targeting of HER2 positive tumors (SKOV-3) in vivo, with a favorable tumor accumulation. We demonstrated the fluorescence properties and the specific HER2 binding of the bioconjugated dyes in vivo and thus their potential for NIR-II FGS in the cancer setting.